Alpha Tau Medical (DRTS) CFO Levy Raphi Exercises Options, Sells Shares

What Happened

• Levy Raphi, Chief Financial Officer of Alpha Tau Medical (DRTS), exercised stock options to acquire 2,871 shares at $2.98 per share (total exercise cost $8,556) on August 21, 2026, and the same day sold those 2,871 shares in an open-market transaction at $15.00 per share for total proceeds of $43,073. The sequence — exercise followed by an immediate sale — is effectively a cashless exercise; net proceeds before fees and taxes were roughly $34,517.

Key Details

• Transaction dates: August 21, 2026 (exercise and sale)
• Exercise price: $2.98 per share; shares acquired: 2,871; cost: $8,556
• Sale price: $15.00 per share; shares sold: 2,871; proceeds: $43,073
• Transaction codes on Form 4: M = option exercise; S = sale (open market)
• Shares owned after the transaction: not specified in the provided filing excerpt
• Filing timeliness: Form 4 was filed Aug 25, 2026 — within the SEC’s two-business-day window for reporting (timely)

Context

• This was a derivative exercise followed by an immediate sale (cashless exercise), a common way for insiders to cover option exercise costs and taxes. Such transactions are routine and do not, by themselves, indicate an insider’s long-term view of the company.